Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Temporal Interference for Essential Tremor

Key facts

Where
Beijing, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 30 and 70 years old?

Source: NCT07016425, who can take part

Where in China

  • Xuanwu Hospital, Capital Medical UniversityBeijing, ChinaContact: Liankun Ren, MDTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Liankun_Ren
Trial code
NCT07016425
Record updated
16 July 2025
Original description
This single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in essential tremor patients aged 30-70.Read full original descriptionShow less

Efficacy and Safety of Non-invasive Temporal Interference Stimulation in the Treatment of Essential Tremor: A Pilot Trial

This single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in essential tremor patients aged 30-70.

Inclusion: Aged 30-70 years old, regardless of gender. Action tremor and postural tremor in both upper limbs, or action tremor and postural tremor in one limb; No history of mental diseases; Informed consent signed.

Exclusion: Patients taking antipsychotic or antidepressant medications; Presence of other neurological diseases affecting the study (such as epilepsy); Patients with moderate to severe cognitive impairment (Montreal Cognitive Assessment ≤ 18 points); Orthopedic diseases that may affect motor symptoms; Presence of metal implants in the body (such as brain pacemakers or cardiac pacemakers); History of electroconvulsive therapy; Presence of cardiovascular risk factors, etc.

ClinicalTrials.gov NCT07016425